OptiNose, Inc. provided earnings guidance for the first quarter of 2024. For the quarter, the Company expects XHANCE net revenues for the first quarter 2024 will be approximately $13.0 million.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.19 USD | -4.03% | +14.42% | -7.75% |
May. 20 | OptiNose, Inc. announced that it has received $4.68 million in funding | CI |
May. 14 | Transcript : OptiNose, Inc., Q1 2024 Earnings Call, May 14, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.75% | 172M | |
+51.54% | 795B | |
+42.31% | 627B | |
-7.20% | 350B | |
+18.67% | 328B | |
+7.48% | 294B | |
+17.94% | 245B | |
+1.35% | 222B | |
+12.11% | 215B | |
+3.64% | 160B |
- Stock Market
- Equities
- OPTN Stock
- News OptiNose, Inc.
- OptiNose, Inc. Provides Earnings Guidance for the First Quarter of 2024